15-Deoxy-Δ (12,14)-PGJ2 inhibits astrocyte IL-1 signaling: Inhibition of NF-κB and MAP kinase pathways and suppression of cytokine and chemokine expression

Journal of Neuroimmunology

Volumn 153, Issue 1-2, 2004, Pages 132-142

  Zhao, Meng Liang ^a   Brosnan, Celia F ^a   Lee, Sunhee C ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Human; IL 8 CXCL8; Inflammation; IP 10 CXCL10; Prostaglandin

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; ALPHA CHEMOKINE; CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROSTAGLANDIN; RANTES; STAT PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ARTICLE; ASTROCYTE; CELL ACTIVATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FETUS; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE MIGRATION INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ASTROCYTES; BIOLOGICAL RESPONSE MODIFIERS; BLOTTING, WESTERN; CELLS, CULTURED; CHEMOKINES; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FETUS; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; INTERLEUKIN-1; MAP KINASE SIGNALING SYSTEM; NF-KAPPA B; NITRITES; PROSTAGLANDIN D2; TIME FACTORS;

EID: 3242677160     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2004.05.003     Document Type: Article

References (54)

1. Appay V., Rowland-Jones S.L. RANTES: a versatile and controversial chemokine. Trends Immunol. 22:2001;83-87
2. Bain J., McLauchlan H., Elliott M., Cohen P. The specificities of protein kinase inhibitors: an update. Biochem. J. 371:2003;199-204
3. + T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions. Proc. Natl. Acad. Sci. U. S. A. 96:1999;6873-6878
4. Belperio J.A., Keane M.P., Arenberg D.A., Addison C.L., Ehlert J.E., Burdick M.D., Strieter R.M. CXC chemokines in angiogenesis. J. Leukoc. Biol. 68:2000;1-8
5. Bernardo A., Levi G., Minghetti L. Role of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its natural ligand 15-deoxy-Delta12,14-prostaglandin J2 in the regulation of microglial functions. Eur. J. Neurosci. 12:2000;2215-2223
6. Bernardo A., Ajmone-Cat M.A., Levi G., Minghetti L. 15-Deoxy-delta12,14- prostaglandin J2 regulates the functional state and the survival of microglial cells through multiple molecular mechanisms. J. Neurochem. 87:2003;742-751
7. Chawla A., Barak Y., Nagy L., Liao D., Tontonoz P., Evans R.M. PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat. Med. 7:2001;48-52
8. Cheng G., Nazar A.S., Shin H.S., Vanguri P., Shin M.L. IP-10 gene transcription by virus in astrocytes requires cooperation of ISRE with adjacent kappaB site but not IRF-1 or viral transcription. J. Interferon Cytokine Res. 18:1998;987-997
9. Clark R.B. The role of PPARs in inflammation and immunity. J. Leukoc. Biol. 71:2002;388-400
10. Davies S.P., Reddy H., Caivano M., Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351:2000;95-105
11. Diab A., Deng C., Smith J.D., Hussain R.Z., Phanavanh B., Lovett-Racke A.E., Drew P.D., Racke M.K. Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta (12,14)-prostaglandin J (2) ameliorates experimental autoimmune encephalomyelitis. J. Immunol. 168:2002;2508-2515
12. Dong Y., Benveniste E.N. Immune function of astrocytes. Glia. 36:2001;180-190
13. Feinstein D.L. Therapeutic potential of peroxisome proliferator-activated receptor agonists for neurological disease. Diabetes Technol. Ther. 5:2003;67-73
14. Feinstein D.L., Galea E., Gavrilyuk V., Brosnan C.F., Whitacre C.C., Dumitrescu-Ozimek L., Landreth G.E., Pershadsingh H.A., Weinberg G., Heneka M.T. Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis. Ann. Neurol. 51:2002;694-702
15. Gilroy D.W., Colville-Nash P.R., Willis D., Chivers J., Paul-Clark M.J., Willoughby D.A. Inducible cyclooxygenase may have anti-inflammatory properties. Nat. Med. 5:1999;698-701
16. Harris S.G., Padilla J., Koumas L., Ray D., Phipps R.P. Prostaglandins as modulators of immunity. Trends Immunol. 23:2002;144-150
17. Harris S.G., Smith R.S., Phipps R.P. 15-Deoxy-Delta 12,14-PGJ2 induces IL-8 production in human T cells by a mitogen-activated protein kinase pathway. J. Immunol. 168:2002;1372-1379
18. Hipp M.S., Urbich C., Mayer P., Wischhusen J., Weller M., Kracht M., Spyridopoulos I. Proteasome inhibition leads to NF-kappaB-independent IL-8 transactivation in human endothelial cells through induction of AP-1. Eur. J. Immunol. 32:2002;2208-2217
19. Hoffmann E., Dittrich-Breiholz O., Holtmann H., Kracht M. Multiple control of interleukin-8 gene expression. J. Leukoc. Biol. 72:2002;847-855
20. Hua L.L., Lee S.C. Distinct patterns of stimulus-inducible chemokine mRNA accumulation in human fetal astrocytes and microglia. Glia. 30:2000;74-81
21. Hua L.L., Liu J.S.H., Brosnan C.F., Lee S.C. Selective inhibition of human glial inducible nitric oxide synthase expression by interferon-beta: implications for multiple sclerosis. Ann. Neurol. 43:1998;384-387
22. Hua L.L., Kim M.O., Brosnan C.F., Lee S.C. Modulation of astrocyte inducible nitric oxide synthase and cytokine expression by IFN is associated with induction and inhibition of GAS binding activity. J. Neurochem. 83:2002;1120-1128
23. Hua L.L., Zhao M.-L., Cosenza M., Kim M.O., Huang H., Tanowitz H.B., Brosnan C.F., Lee S.C. Role of mitogen-activated protein kinases in inducible nitric oxide synthase and TNFa expression in human fetal astrocytes. J. Neuroimmunol. 126:2002;180-189
24. Janabi N. Selective inhibition of cyclooxygenase-2 expression by 15-deoxy-Delta (12,14) (12,14)-prostaglandin J (2) in activated human astrocytes, but not in human brain macrophages. J. Immunol. 168:2002;4747-4755
25. John G.R., Simpson J.E., Woodroofe M.N., Lee S.C., Brosnan C.F. Extracellular nucleotides differentially regulate interleukin-1beta signaling in primary human astrocytes: implications for inflammatory gene expression. J. Neurosci. 21:2001;4134-4142
26. John G.R., Lee S.C., Brosnan C.F. Cytokines: powerful regulators of glial cell activation. Neuroscientist. 9:2003;10-22
27. Karin M., Ben Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18:2000;621-663
28. Lee S.C., Brosnan C.F. Molecular biology of glia: astrocytes. Russell W.C. Molecular Biology of Multiple Sclerosis. 1997;71-96 John Wiley & Sons, Chichester, U.K.
29. Lee S.C., Liu W., Brosnan C.F., Dickson D.W. Characterization of human fetal dissociated CNS cultures with an emphasis on microglia. Lab. Invest. 67:1992;465-475
30. Lee S.C., Liu W., Dickson D.W., Brosnan C.F., Berman J.W. Cytokine production by human fetal microglia and astrocytes: differential induction by LPS and IL-1β J. Immunol. 150:1993;2659-2667
31. Lee S.C., Liu W., Roth P., Dickson D.W., Berman J.W., Brosnan C.F. Macrophage colony stimulating factor (CSF-1) in astrocytes and microglia: differential regulation by cytokines and LPS and inhibition of class II MHC expression on microglia. J. Immunol. 150:1993;594-604
32. Lennon A.M., Ramauge M., Dessouroux A., Pierre M. MAP kinase cascades are activated in astrocytes and preadipocytes by 15-deoxy-Delta (12-14)-prostaglandin J (2) and the thiazolidinedione ciglitazone through peroxisome proliferator activator receptor gamma-independent mechanisms involving reactive oxygenated species. J. Biol. Chem. 277:2002;29681-29685
33. Lin R., Heylbroeck C., Genin P., Pitha P.M., Hiscott J. Essential role of interferon-regulatory factor 3 in direct activation of RANTES chemokine transcription. Mol. Cell. Biol. 19:1999;959-966
34. Liu J., Zhao M.-L., Brosnan C.F., Lee S.C. Expression of type II nitric oxide synthase in primary human astrocytes and microglia: role of IL-1β and IL-1 receptor antagonist. J. Immunol. 157:1996;3569-3576
35. Liu J.S.H., Amaral T., Brosnan C.F., Lee S.C. Interferons are critical regulators of IL-1b and IL-1ra expression in human fetal microglia. J. Immunol. 161:1998;1989-1996
36. Liu J.S.H., John G.R., Sikora A., Lee S.C., Brosnan C.F. Modulation of IL-1β and TNFα signaling by P2 purinergic receptors in human fetal astrocytes. J. Neurosci. 20:2000;5292-5299
37. Liu J.S.H., Zhao M.L., Brosnan C.F., Lee S.C. Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. Am. J. Pathol. 158:2001;2057-2066
38. Luster A.D. Chemokines - chemotactic cytokines in inflammation. N. Engl. J. Med. 338:1998;436-445
39. Mercurio F., Manning A.M. Multiple signals converging on NF-kB. Curr. Opin. Cell Biol. 11:1999;226-232
40. Mukundan L., Milhorn D.M., Matta B., Suttles J. CD40-mediated activation of vascular smooth muscle cell chemokine production through a Src-initiated, MAPK-dependent pathway. Cell Signal. 16:2004;375-384
41. Park E.J., Park S.Y., Joe E.H., Jou I. 15d-PGJ2 and rosiglitazone suppress Janus kinase-STAT inflammatory signaling through induction of suppressor of cytokine signaling 1 (SOCS1) and SOCS3 in glia. J. Biol. Chem. 278:2003;14747-14752
42. Petrova T.V., Akama K.T., Van Eldik L.J. Cyclopentenone prostaglandins suppress activation of microglia: down- regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2. Proc. Natl. Acad. Sci. U. S. A. 96:1999;4668-4673
43. Ransohoff R.M., Kivisakk P., Kidd G. Three or more routes for leukocyte migration into the central nervous system. Nat. Rev. Immunol. 3:2003;569-581
44. Ricote M., Li A.C., Willson T.M., Kelly C.J., Glass C.K. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature. 391:1998;79-82
45. Rollins B.J. Chemokines. Blood. 90:1997;909-928
46. Rossi A., Kapahi P., Natoli G., Takahashi T., Chen Y., Karin M., Santoro M.G. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature. 403:2000;103-108
47. Schulze-Osthoff K., Ferrari D., Riehemann K., Wesselborg S. Regulation of NF-kB activation by MAP kinase cascade. Immunobiology. 198:1997;35-49
48. Shibata T., Kondo M., Osawa T., Shibata N., Kobayashi M., Uchida K. 15-Deoxy-delta 12,14-prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory processes. J. Biol. Chem. 277:2002;10459-10466
49. Sorensen T.L., Tani M., Jensen J., Pierce V., Lucchinetti C., Folcik V.A., Qin S., Rottman J., Sellebjerg F., Strieter R.M., Frederiksen J.L., Ransohoff R.M. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Invest. 103:1999;807-815
50. Straus D.S., Pascual G., Li M., Welch J.S., Ricote M., Hsiang C.H., Sengchanthalangsy L.L., Ghosh G., Glass C.K. 15-Deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc. Natl. Acad. Sci. U. S. A. 97:2000;4844-4849
51. Thieringer R., Fenyk-Melody J.E., Le Grand C.B., Shelton B.A., Detmers P.A., Somers E.P., Carbin L., Moller D.E., Wright S.D., Berger J. Activation of peroxisome proliferator-activated receptor gamma does not inhibit IL-6 or TNF-alpha responses of macrophages to lipopolysaccharide in vitro or in vivo. J. Immunol. 164:2000;1046-1054
52. Vanden Berghe W., Plaisance S., Boone E., De Bosscher K., Schmitz M.L., Fiers W., Haegeman G. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor. J. Biol. Chem. 273:1998;3285-3290
53. Welch J.S., Ricote M., Akiyama T.E., Gonzalez F.J., Glass C.K. PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages. Proc. Natl. Acad. Sci. U. S. A. 100:2003;6712-6717
54. Zhang X., Wang J.M., Gong W.H., Mukaida N., Young H.A. Differential regulation of chemokine gene expression by 15-deoxy-delta 12,14 prostaglandin J2. J. Immunol. 166:2001;7104-7111